title: Letter from the editor.
authors.affiliation: Senior Vice President R&D and Chief Technology Officer; NasVax, Ltd.; Ness Ziona, Israel.
authors.forename: Ronald
authors.initials: R
authors.lastname: Ellis
authors.forename: Eva M
authors.initials: EM
authors.lastname: Riedmann
mesh_terms: D001424:Bacterial Infections / Q000517:prevention & control*; D035081:Editorial Policies; D006373:Helminthiasis / Q000517:prevention & control*; D006801:Humans; D020407:Internet; D010506:Periodicals as Topic; D014611:Vaccination / Q000379:methods*; D014612:Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology* / Q000302:isolation & purification; D014777:Virus Diseases / Q000517:prevention & control*
chemical_list: D014612:Vaccines